Previous 10 | Next 10 |
Neximmune press release (NASDAQ:NEXI): Q1 GAAP EPS of -$0.66 beats by $0.05. Based upon current operating plans, the company expects that its existing cash, cash equivalents and marketable securities of $65M will enable the Company to fund its operating and capital expenditure requirements in...
Clinical data updates for the Company’s two lead product candidates in Phase 1/2 clinical trials expected in 2H2022 Investigational New Drug (IND) submission for NEXI-003, the Company’s first product for solid tumors, planned for 1H2022 Plans to report ad...
A JDRF funded grant will be used to explore the combination of NexImmune’s antigen specific nanoparticles and an anti-CD3 mAb for prevention and treatment of type 1 diabetes GAITHERSBURG, Md., May 10, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI...
GAITHERSBURG, Md., May 10, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announ...
GAITHERSBURG, Md., April 26, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today anno...
Gainers: Clarus Therapeutics Holdings (CRXT) +87%. Winc (WBEV) +27%. AlloVir (ALVR) +26%. NexImmune (NEXI) +24%. Charah Solutions (CHRA) +22%. Target Hospitality (TH) +20%. Phio Pharmaceuticals (PHIO) +20%. Healthcare Services Group (HCSG) +19%. CEL-SCI (CVM) +18%. Biophytis (BPTS) +17%. Lose...
Clinical-stage biotech company NexImmune (NASDAQ:NEXI) on Thursday promoted Mathias Oelke to chief scientific officer. Oelke had served as senior vice president, preclinical immunotherapy and head of cell biology at NEXI since 2017. Oelke was previously a member of the faculty at the Joh...
GAITHERSBURG, Md., April 14, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today anno...
Executive Chair Bill Ford picked up $4.5 million worth of Ford stock on the open market last week. Automotive part manufacturer LCI Industries saw a cluster of three insiders purchase shares. Insiders are buying ahead of an earnings related blackout period. For further detai...
Want to find the best penny stocks to buy now ? Many investors and traders use the “follow the money” approach to trading. They’re hunting for SEC filings that show management or institutions taking positions or adding to their current positions. It sounds taboo, bu...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...